Home Podcasts Dealcast: The M&A Podcast
Dealcast: The M&A Podcast

Dealcast: The M&A Podcast

ION Analytics 268 episodes Latest May 18, 2026

Dealcast: The M&A Podcast is a weekly podcast from the Mergermarket editorial team covering M&A, ECM and activism. It is presented by Mergermarket, a leading provider of M&A data and intelligence.

Episodes

13: Dealcast: Vertical farming grows up Nov 13, 2019 9:51 Could tomorrow’s groceries come from a lab? Today’s vertical-farming startups aim to grow food in tightly controlled indoor stacks, solving a host of problems – blight, water wastage and a shortage of land – at once. Leading the way are such firms as the UK’s Intelligent Growth Solutions, Belgium’s Urban Crop Solutions and Italy’s Planet Farms, all of which featured in recent Mergermarket coverage
12: Dealcast: Allergan reaction Aug 9, 2019 13:07 The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. De
11: Dealcast: KKR’s play for Axel Springer Jun 20, 2019 10:02 German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future.
10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM Jun 14, 2019 15:41 In this weekly edition of Dealreporter Asia Pacific’s podcast, Anette Jönsson and Ed Vinales discuss key deals and developments relevant to Asia event-driven investors, including AGL Energy’s [ASX:AGL] new indicative offer for Australian telecom company Vocus [ASX:VOC], private equity interest in Australian healthcare provider Healius [ASX:ALS] and corporate governance-related investing in Japan.
9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling May 31, 2019 18:14 In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon James Packer selling par
8: Tipping Point: Deal Terms Oct 13, 2020 27:19 Seyfarth’s Paul Pryzant and SRS Acquiom's Chris Letang join Tom Cane to discuss how the shift from a seller’s to a buyer’s M&A market this year has impacted the deal terms being agreed in the mid-market, from an increase in earn-outs and termination fees to the impact of the pandemic on reps and warranties. Paul and Chris also discuss how technology is changing the due diligence process.
8: Dealcast: Tech listings go awry May 29, 2019 9:21 Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.
The European SPACs boom and SS&C Intralinks Deal Flow Predictor Mar 30, 2021 20:27 The SS&C Intralinks Deal Flow Predictor provides a six-month view of global and regional M&A activity and a wealth of actionable market intelligence. Read the latest edition of the SS&C Intralinks Deal Flow Predictor to find out the data-driven M&A forecast for the next six months, by region and globally. This edition also features:• A spotlight feature, “Breaking Up Big Tech,” cha
7: Dealcast: Covid-19 and healthcare M&A Apr 29, 2020 18:26 No sector is closer than healthcare to the front-lines of the covid-19 pandemic. Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A. In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa
7: Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals May 24, 2019 12:04 In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin Electric, and the ongoin
Conference coverage: Tulane Law School's virtual conference Mar 30, 2021 16:51 We’ve made it easier to go from selling to sold.Our easy-to-use M&A Checklist drawn from more than 20 years of VDR experience ensures you have everything you need to get the deal done. Never missing a step means deals go full speed ahead.For a limited time, get your M&A Checklist covering key areas, including:FinanceLabor relationsIntellectual propertyRegulatory and legal mattersPlus 8 mor
6: Tipping Point: Learning Good Habits in Bad Times Apr 24, 2020 26:36 US asset and wealth management M&A saw a significant uptick before the coronavirus pandemic, fueled in part by aging registered investment advisors looking to sell at high valuations amid a booming stock market. While current volatility has put the brakes on activity, some deals are still getting done and the longer term prospects look healthy, notably driven by strong interest from private eq

Recommended

Playing